T cells are the 'foot soldiers' that fight cancer inside the body. Cancer cells can fight the foot soldiers back by pushing a brake on the T cells that will turn them off. This 'brake' is a molecule ...
A CTLA-4 gene polymorphism at position −318 in the promoter region affects the expression of protein
CTLA-4 plays an important role in the immune system as a T cell inhibitory factor. This inhibitory signal not only determines whether T cells become activated, but also affects the clonal ...
Preliminary findings from part 1 of COMBI-i: A phase III study of anti–PD-1 antibody PDR001 combined with dabrafenib (D) and trametinib (T) in previously untreated patients (pts) with advanced BRAF ...
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that it has entered into a collaboration with Memorial Sloan Kettering Cancer Center (MSKCC) to advance a Phase II clinical study ...
We are writing to provide clarification and correction to our article “Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma” (Dec. 4, 2014, issue). 1 Along with the publication, ...
Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a protein receptor on T immune cells that prevents the cells from killing other cells, such as cancer cells. Blocking CTLA-4 with a specific antibody is an ...
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is an immunogenic protein receptor that is expressed almost exclusively on CD4+ and CD8+ T cells. It plays a crucial role in the homeostasis of ...
MONROVIA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and ...
T cells are the 'foot soldiers' that fight cancer inside the body. Cancer cells can fight the foot soldiers back by pushing a brake on the T cells that will turn them off. This 'brake' is a molecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results